在乳腺癌进展和转移中,RAGE及其连接物
Madalina Coser1, Bogdan Mihai Neamtu2,3, Bogdan Pop4,5
1Department of Histology, Doctoral School "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania.
Oncology reviews
|January 20, 2025
概括
先进糖化终产品 (RAGE) 的受体及其连接体在乳腺癌的进展和转移中发挥着关键作用. 针对RAGE提供了新的乳腺癌疗法和预后生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 乳腺癌是全球癌症死亡的主要原因之一.
- 先进糖化终产品 (RAGE) 的受体及其连接物越来越多地与癌症进展有关.
研究的目的:
- 审查RAGE及其配体在乳腺癌生长和转移中的作用.
- 评估RAGE多态性和乳腺癌风险之间的关系.
主要方法:
- 在PubMed.com上对90篇文章进行了广泛的综述.
- 对RAGE rs1800624多态性和乳腺癌风险的元分析.
主要成果:
- 激活RAGE促进乳腺癌细胞迁移,生长,血管新生,转移和耐药性.
- RAGE及其连接物调节瘤微环境,以增强瘤的生长.
- 乳腺癌中的高RAGE表达与预后不佳相关.
结论:
- 准RAGE及其配体可以损害乳腺癌的入侵和转移.
- RAGE及其配体显示出作为乳腺癌预后生物标志物和治疗点的潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


